123 related articles for article (PubMed ID: 23649333)
1. Macrophage migration inhibitory factor is a possible candidate for the induction of microalbuminuria in diabetic db/db mice.
Watanabe T; Tomioka NH; Doshi M; Watanabe S; Tsuchiya M; Hosoyamada M
Biol Pharm Bull; 2013; 36(5):741-7. PubMed ID: 23649333
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of macrophage migration inhibitory factor reduces diabetic nephropathy in type II diabetes mice.
Wang Z; Wei M; Wang M; Chen L; Liu H; Ren Y; Shi K; Jiang H
Inflammation; 2014 Dec; 37(6):2020-9. PubMed ID: 24958012
[TBL] [Abstract][Full Text] [Related]
3. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury.
Chow F; Ozols E; Nikolic-Paterson DJ; Atkins RC; Tesch GH
Kidney Int; 2004 Jan; 65(1):116-28. PubMed ID: 14675042
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional Profile of Kidney from Type 2 Diabetic db/db Mice.
Zhang H; Zhao T; Li Z; Yan M; Zhao H; Zhu B; Li P
J Diabetes Res; 2017; 2017():8391253. PubMed ID: 28232950
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of atherosclerotic lesions in diabetic apolipoprotein E-deficient mice using gene silencing of macrophage migration inhibitory factor.
Sun H; Zhang X; Zhao L; Zhen X; Huang S; Wang S; He H; Liu Z; Xu N; Yang F; Qu Z; Ma Z; Zhang C; Zhang Y; Hu Q
J Cell Mol Med; 2015 Apr; 19(4):836-49. PubMed ID: 25661015
[TBL] [Abstract][Full Text] [Related]
6. Laser capture microdissection/GeneChip analysis of gene expression in glomerular cells in diabetic db/db mice.
Naito Y; Uchiyama K; Kuroda M; Mizushima K; Aoi W; Kokura S; Ichikawa H; Yoshida N; Yoshikawa T
Redox Rep; 2004; 9(6):307-12. PubMed ID: 15720823
[TBL] [Abstract][Full Text] [Related]
7. Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice.
Fujii M; Inoguchi T; Maeda Y; Sasaki S; Sawada F; Saito R; Kobayashi K; Sumimoto H; Takayanagi R
Kidney Int; 2007 Aug; 72(4):473-80. PubMed ID: 17568784
[TBL] [Abstract][Full Text] [Related]
8. Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes.
Zhang D; Yang H; Kong X; Wang K; Mao X; Yan X; Wang Y; Liu S; Zhang X; Li J; Chen L; Wu J; Wei M; Yang J; Guan Y
Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E287-95. PubMed ID: 20959534
[TBL] [Abstract][Full Text] [Related]
9. Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes.
Sedeek M; Gutsol A; Montezano AC; Burger D; Nguyen Dinh Cat A; Kennedy CR; Burns KD; Cooper ME; Jandeleit-Dahm K; Page P; Szyndralewiez C; Heitz F; Hebert RL; Touyz RM
Clin Sci (Lond); 2013 Feb; 124(3):191-202. PubMed ID: 22920224
[TBL] [Abstract][Full Text] [Related]
10. MIF 173 G>C variation was associated with depressive disorder in type 2 diabetes in an Iranian population.
Hamidi AK; Arzaghi SM; Qorbani M; Khatami F; Ebrahimi M; Bandarian F; Enayati S; Amoli MM
Psychoneuroendocrinology; 2019 Jun; 104():243-248. PubMed ID: 30903991
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous Nuclear Ribonucleoprotein F Stimulates Sirtuin-1 Gene Expression and Attenuates Nephropathy Progression in Diabetic Mice.
Lo CS; Shi Y; Chenier I; Ghosh A; Wu CH; Cailhier JF; Ethier J; Lattouf JB; Filep JG; Ingelfinger JR; Zhang SL; Chan JSD
Diabetes; 2017 Jul; 66(7):1964-1978. PubMed ID: 28424160
[TBL] [Abstract][Full Text] [Related]
12. DBA2J db/db mice are susceptible to early albuminuria and glomerulosclerosis that correlate with systemic insulin resistance.
Østergaard MV; Pinto V; Stevenson K; Worm J; Fink LN; Coward RJ
Am J Physiol Renal Physiol; 2017 Feb; 312(2):F312-F321. PubMed ID: 27852608
[TBL] [Abstract][Full Text] [Related]
13. Cytochemical analysis of pancreatic islet hypercytolipidemia following diabetes (db/db) and obese (ob/ob) mutation expression: influence of genomic background.
Garris DR; Garris BL
Pathobiology; 2004; 71(5):231-40. PubMed ID: 15459481
[TBL] [Abstract][Full Text] [Related]
14. Altered vitamin D metabolism in type II diabetic mouse glomeruli may provide protection from diabetic nephropathy.
Wang Y; Zhou J; Minto AW; Hack BK; Alexander JJ; Haas M; Li YC; Heilig CW; Quigg RJ
Kidney Int; 2006 Sep; 70(5):882-91. PubMed ID: 16820793
[TBL] [Abstract][Full Text] [Related]
15. Macrophage migration inhibitory factor and development of type-1 diabetes in non-obese diabetic mice.
Bojunga J; Kusterer K; Bacher M; Kurek R; Usadel KH; Renneberg H
Cytokine; 2003 Feb; 21(4):179-86. PubMed ID: 12788306
[TBL] [Abstract][Full Text] [Related]
16. Long-term expression of glomerular genes in diabetic nephropathy.
Chittka D; Banas B; Lennartz L; Putz FJ; Eidenschink K; Beck S; Stempfl T; Moehle C; Reichelt-Wurm S; Banas MC
Nephrol Dial Transplant; 2018 Sep; 33(9):1533-1544. PubMed ID: 29340699
[TBL] [Abstract][Full Text] [Related]
17. Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer.
He LJ; Xie D; Hu PJ; Liao YJ; Deng HX; Kung HF; Zhu SL
World J Gastroenterol; 2015 Sep; 21(34):9916-26. PubMed ID: 26379396
[TBL] [Abstract][Full Text] [Related]
18. Plasma Macrophage Migration Inhibitor Factor Is Elevated in Response to Myocardial Ischemia.
Fan F; Fang L; Moore XL; Xie X; Du XJ; White DA; O'Brien J; Thomson H; Wang J; Schneider HG; Ellims A; Barber TW; Dart AM
J Am Heart Assoc; 2016 Jun; 5(7):. PubMed ID: 27364992
[TBL] [Abstract][Full Text] [Related]
19. Role of macrophage migration inhibitory factor in corneal neovascularization.
Usui T; Yamagami S; Kishimoto S; Seiich Y; Nakayama T; Amano S
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3545-50. PubMed ID: 17652722
[TBL] [Abstract][Full Text] [Related]
20. Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.
Chen L; Zhou X; Fan LX; Yao Y; Swenson-Fields KI; Gadjeva M; Wallace DP; Peters DJ; Yu A; Grantham JJ; Li X
J Clin Invest; 2015 Jun; 125(6):2399-412. PubMed ID: 25961459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
